MicroRNA-340 inhibits the growth and invasion of angiosarcoma cells by targeting SIRT7
MicroRNAs (miRNAs) are emerging as critical regulators for the development and progression of various cancers, including angiosarcoma. Accumulating evidence suggests that miRNA-340 (miR-340) is an important cancer-associated miRNA. However, little is known about the role of miR-340 in angiosarcoma....
Saved in:
| Published in | Biomedicine & pharmacotherapy Vol. 103; pp. 1061 - 1068 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
France
Elsevier Masson SAS
01.07.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | MicroRNAs (miRNAs) are emerging as critical regulators for the development and progression of various cancers, including angiosarcoma. Accumulating evidence suggests that miRNA-340 (miR-340) is an important cancer-associated miRNA. However, little is known about the role of miR-340 in angiosarcoma. In this study, we aimed to investigate the potential biological functions of miR-340 and its potential target gene in angiosarcoma. Our results showed that miR-340 expression was significantly decreased in angiosarcoma compared with normal controls. The overexpression of miR-340 inhibited the growth and invasion of angiosarcoma cells, while the inhibition of miR-340 showed the opposite effect. Bioinformatics analysis predicted that Sirtuin 7 (SIRT7) was a potential target gene of miR-340. The binding relationship between miR-340 and the SIRT7 3′-untranslated region was verified by dual-luciferase reporter assay. Moreover, our results showed that miR-340 negatively regulated SIRT7 expression in angiosarcoma cells and an inverse correlation between miR-340 and SIRT7 expression was shown in clinical angiosarcoma tissues. We found that silencing SIRT7 significantly inhibited the proliferation and invasion of angiosarcoma cells. Notably, the overexpression of SIRT7 promoted the proliferation and invasion of angiosarcoma cells and also partially reversed the antitumor effect of miR-340 on angiosarcoma cell proliferation and invasion. Taken together, our results demonstrate that miR-340 inhibits the growth and invasion of angiosarcoma cells by targeting SIRT7. Our study provides evidence that the miR-340/SIRT7 axis may play an important role in the molecular pathogenesis of angiosarcoma and suggests that miR-340 and SIRT7 may be used as potential and novel therapeutic targets for the treatment of angiosarcoma. |
|---|---|
| AbstractList | MicroRNAs (miRNAs) are emerging as critical regulators for the development and progression of various cancers, including angiosarcoma. Accumulating evidence suggests that miRNA-340 (miR-340) is an important cancer-associated miRNA. However, little is known about the role of miR-340 in angiosarcoma. In this study, we aimed to investigate the potential biological functions of miR-340 and its potential target gene in angiosarcoma. Our results showed that miR-340 expression was significantly decreased in angiosarcoma compared with normal controls. The overexpression of miR-340 inhibited the growth and invasion of angiosarcoma cells, while the inhibition of miR-340 showed the opposite effect. Bioinformatics analysis predicted that Sirtuin 7 (SIRT7) was a potential target gene of miR-340. The binding relationship between miR-340 and the SIRT7 3′-untranslated region was verified by dual-luciferase reporter assay. Moreover, our results showed that miR-340 negatively regulated SIRT7 expression in angiosarcoma cells and an inverse correlation between miR-340 and SIRT7 expression was shown in clinical angiosarcoma tissues. We found that silencing SIRT7 significantly inhibited the proliferation and invasion of angiosarcoma cells. Notably, the overexpression of SIRT7 promoted the proliferation and invasion of angiosarcoma cells and also partially reversed the antitumor effect of miR-340 on angiosarcoma cell proliferation and invasion. Taken together, our results demonstrate that miR-340 inhibits the growth and invasion of angiosarcoma cells by targeting SIRT7. Our study provides evidence that the miR-340/SIRT7 axis may play an important role in the molecular pathogenesis of angiosarcoma and suggests that miR-340 and SIRT7 may be used as potential and novel therapeutic targets for the treatment of angiosarcoma. MicroRNAs (miRNAs) are emerging as critical regulators for the development and progression of various cancers, including angiosarcoma. Accumulating evidence suggests that miRNA-340 (miR-340) is an important cancer-associated miRNA. However, little is known about the role of miR-340 in angiosarcoma. In this study, we aimed to investigate the potential biological functions of miR-340 and its potential target gene in angiosarcoma. Our results showed that miR-340 expression was significantly decreased in angiosarcoma compared with normal controls. The overexpression of miR-340 inhibited the growth and invasion of angiosarcoma cells, while the inhibition of miR-340 showed the opposite effect. Bioinformatics analysis predicted that Sirtuin 7 (SIRT7) was a potential target gene of miR-340. The binding relationship between miR-340 and the SIRT7 3'-untranslated region was verified by dual-luciferase reporter assay. Moreover, our results showed that miR-340 negatively regulated SIRT7 expression in angiosarcoma cells and an inverse correlation between miR-340 and SIRT7 expression was shown in clinical angiosarcoma tissues. We found that silencing SIRT7 significantly inhibited the proliferation and invasion of angiosarcoma cells. Notably, the overexpression of SIRT7 promoted the proliferation and invasion of angiosarcoma cells and also partially reversed the antitumor effect of miR-340 on angiosarcoma cell proliferation and invasion. Taken together, our results demonstrate that miR-340 inhibits the growth and invasion of angiosarcoma cells by targeting SIRT7. Our study provides evidence that the miR-340/SIRT7 axis may play an important role in the molecular pathogenesis of angiosarcoma and suggests that miR-340 and SIRT7 may be used as potential and novel therapeutic targets for the treatment of angiosarcoma.MicroRNAs (miRNAs) are emerging as critical regulators for the development and progression of various cancers, including angiosarcoma. Accumulating evidence suggests that miRNA-340 (miR-340) is an important cancer-associated miRNA. However, little is known about the role of miR-340 in angiosarcoma. In this study, we aimed to investigate the potential biological functions of miR-340 and its potential target gene in angiosarcoma. Our results showed that miR-340 expression was significantly decreased in angiosarcoma compared with normal controls. The overexpression of miR-340 inhibited the growth and invasion of angiosarcoma cells, while the inhibition of miR-340 showed the opposite effect. Bioinformatics analysis predicted that Sirtuin 7 (SIRT7) was a potential target gene of miR-340. The binding relationship between miR-340 and the SIRT7 3'-untranslated region was verified by dual-luciferase reporter assay. Moreover, our results showed that miR-340 negatively regulated SIRT7 expression in angiosarcoma cells and an inverse correlation between miR-340 and SIRT7 expression was shown in clinical angiosarcoma tissues. We found that silencing SIRT7 significantly inhibited the proliferation and invasion of angiosarcoma cells. Notably, the overexpression of SIRT7 promoted the proliferation and invasion of angiosarcoma cells and also partially reversed the antitumor effect of miR-340 on angiosarcoma cell proliferation and invasion. Taken together, our results demonstrate that miR-340 inhibits the growth and invasion of angiosarcoma cells by targeting SIRT7. Our study provides evidence that the miR-340/SIRT7 axis may play an important role in the molecular pathogenesis of angiosarcoma and suggests that miR-340 and SIRT7 may be used as potential and novel therapeutic targets for the treatment of angiosarcoma. |
| Author | Wang, Xiaoxin Song, Ying |
| Author_xml | – sequence: 1 givenname: Xiaoxin surname: Wang fullname: Wang, Xiaoxin – sequence: 2 givenname: Ying surname: Song fullname: Song, Ying email: song_yingsy@163.com |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29710664$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkF1r2zAYhcXoWNNu_2AMX-7G3qsPy_IYg1LWD-g26NreCll-nShzrExSWvLvp5D2pje5Ejqc5yA9J-Ro8hMS8pFCRYHKL8uqc369MBUDqioQFRXqDZnRtoZSAjRHZAZNzUvOGTsmJzEuAaCWXL0jx6xtKEgpZuThp7PB3_46K7mAwk0L17kUi7TAYh78U1oUZupz_mii81Phh3yfOx9NsH5lCovjGItuWyQT5pjcNC_-XN_eNe_J28GMET88n6fk_uLH3flVefP78vr87Ka0QtFUKjGg7FAKxSyvwdaDNMpwMFJh3QnFGc9ZzlvLaIvWCNVwy2BoEW3Nen5KPu9318H_22BMeuXi7lFmQr-JmgHnvJFtq3L103N1062w1-vgViZs9YuLXPi6L2QhMQYctHXJpPztFIwbNQW9E6-Xei9e78RrEDqLz7B4Bb_sH8C-7zHMkh4dBh2tw8li7wLapHvvDg18ezVgRzc5a8a_uD2M_wcGjbIF |
| CitedBy_id | crossref_primary_10_1016_j_tranon_2022_101385 crossref_primary_10_1007_s11033_024_10205_4 crossref_primary_10_3390_cancers15030577 crossref_primary_10_1111_jcmm_15899 crossref_primary_10_1016_j_cbi_2018_10_003 crossref_primary_10_1158_1541_7786_MCR_23_1075 crossref_primary_10_1002_bio_3733 crossref_primary_10_1155_2020_9568976 crossref_primary_10_3390_cancers12123709 crossref_primary_10_1016_j_semcancer_2020_07_003 crossref_primary_10_1158_1541_7786_MCR_22_1008 crossref_primary_10_1186_s12894_021_00935_z crossref_primary_10_1093_advances_nmy129 crossref_primary_10_2174_1389201020666190725112304 crossref_primary_10_1016_j_pharmthera_2020_107748 crossref_primary_10_3390_molecules25204701 crossref_primary_10_1002_1878_0261_13744 crossref_primary_10_1016_j_rvsc_2023_105120 crossref_primary_10_3389_fonc_2024_1385632 |
| Cites_doi | 10.1093/annonc/mds237 10.1016/S0092-8674(04)00045-5 10.18632/oncotarget.3288 10.3390/ijms161025377 10.1038/nrc1840 10.7554/eLife.05005 10.7150/jca.19315 10.18632/oncotarget.8421 10.1016/j.bbrc.2015.03.088 10.1038/nrc3166 10.1002/hep.26101 10.1097/SLA.0b013e3181dbb75a 10.1016/j.ccr.2012.05.028 10.1080/21541264.2016.1276658 10.1371/journal.pone.0137361 10.1146/annurev.med.59.053006.104707 10.7150/thno.18804 10.1002/cncr.25860 10.1016/j.yexcr.2014.11.001 10.1016/j.cellsig.2014.11.026 10.1158/1078-0432.CCR-13-1547 10.1158/1535-7163.MCT-13-0571 10.1016/j.celrep.2017.01.009 10.1158/0008-5472.CAN-14-0938 10.1016/j.febslet.2013.10.023 10.3892/or.2015.4458 10.1002/gcc.21943 10.1016/j.celrep.2015.08.006 10.1016/j.bbrc.2013.07.033 10.1038/cr.2012.112 10.1101/gad.1399706 10.1016/j.gene.2015.11.045 10.3892/mmr.2017.7224 10.1038/ncb0309-228 10.1038/s41467-017-00396-9 10.1038/nrg1379 10.1007/s40618-018-0848-6 10.1038/nrm3313 10.1016/j.biopha.2017.07.083 10.1038/labinvest.2010.53 10.1152/physiolgenomics.00034.2008 10.1126/science.1073827 10.1002/1873-3468.12138 10.1684/ejd.2017.3084 10.18632/oncotarget.11252 10.1159/000445553 10.1016/j.anndiagpath.2010.07.012 10.1038/srep09841 10.1093/nar/gkm995 10.3892/or.2016.5063 10.3892/mmr.2017.7603 10.1016/j.biochi.2017.10.027 10.3892/or.2016.4876 10.1038/nature11043 10.1038/onc.2014.267 10.1038/srep09787 10.1158/1078-0432.CCR-13-2952 10.1038/s41388-017-0029-7 10.1242/jcs.042382 10.1016/j.dld.2017.10.024 10.1089/dna.2015.3021 |
| ContentType | Journal Article |
| Copyright | 2018 Elsevier Masson SAS Copyright © 2018 Elsevier Masson SAS. All rights reserved. |
| Copyright_xml | – notice: 2018 Elsevier Masson SAS – notice: Copyright © 2018 Elsevier Masson SAS. All rights reserved. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.biopha.2018.04.148 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1950-6007 |
| EndPage | 1068 |
| ExternalDocumentID | 29710664 10_1016_j_biopha_2018_04_148 S0753332218305183 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABMAC ABMZM ABWVN ABXDB ABZDS ACDAQ ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AI. AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALCLG ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HVGLF HZ~ IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OD~ OGGZJ OK1 OO0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SDP SEM SES SEW SPT SSH SSP SSZ T5K VH1 WUQ Z5R ~02 ~G- 0SF AACTN AAIAV AFCTW AFKWA AFPKN AJOXV AMFUW GROUPED_DOAJ NCXOZ RIG AAYXX AGRNS CITATION NPM 7X8 |
| ID | FETCH-LOGICAL-c481t-84fe6be6482c350c5f6a8a30a68e5b48323c5f0c59c219eca4873c20f9eec52d3 |
| IEDL.DBID | .~1 |
| ISSN | 0753-3322 1950-6007 |
| IngestDate | Mon Jul 21 10:28:45 EDT 2025 Wed Feb 19 02:43:30 EST 2025 Tue Jul 01 03:22:58 EDT 2025 Thu Apr 24 23:01:29 EDT 2025 Sat Jul 13 15:31:49 EDT 2024 Tue Aug 26 16:34:52 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | UTR miRNAs miR-340 FBS CCK-8 miRNA SIRT7 Angiosarcoma RT-qPCR |
| Language | English |
| License | Copyright © 2018 Elsevier Masson SAS. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c481t-84fe6be6482c350c5f6a8a30a68e5b48323c5f0c59c219eca4873c20f9eec52d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 29710664 |
| PQID | 2033376998 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_2033376998 pubmed_primary_29710664 crossref_citationtrail_10_1016_j_biopha_2018_04_148 crossref_primary_10_1016_j_biopha_2018_04_148 elsevier_sciencedirect_doi_10_1016_j_biopha_2018_04_148 elsevier_clinicalkey_doi_10_1016_j_biopha_2018_04_148 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-07-01 |
| PublicationDateYYYYMMDD | 2018-07-01 |
| PublicationDate_xml | – month: 07 year: 2018 text: 2018-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | France |
| PublicationPlace_xml | – name: France |
| PublicationTitle | Biomedicine & pharmacotherapy |
| PublicationTitleAlternate | Biomed Pharmacother |
| PublicationYear | 2018 |
| Publisher | Elsevier Masson SAS |
| Publisher_xml | – name: Elsevier Masson SAS |
| References | Li, Sun, Liu (bib0210) 2016; 38 Zhao, Ma, Hu (bib0135) 2018 He, Hannon (bib0020) 2004; 5 Lahat, Dhuka, Hallevi (bib0010) 2010; 251 Nakashima, Jinnin, Kanemaru (bib0175) 2017; 27 Kiran, Oddi, Ramakrishna (bib0260) 2015; 331 Wei, Jing, Ke (bib0105) 2017; 7 Gu, Ran, Liu (bib0310) 2016; 590 Ford, Voit, Liszt (bib0085) 2006; 20 Huang, Zhou, Zhang (bib0125) 2018; 37 Huang, Qiu, Ge (bib0120) 2015; 6 Hutvagner, Zamore (bib0025) 2002; 297 Shi, Ji, Zhang (bib0295) 2016; 36 Garzon, Calin, Croce (bib0055) 2009; 60 Yu, Qin, Wu (bib0275) 2017; 18 Xie, Chen, Liu (bib0130) 2018; 50 Heishima, Mori, Sakai (bib0165) 2015; 10 Han, Liu, Zhang (bib0290) 2013; 587 Yu, Ye, Wu (bib0100) 2014; 20 Sarver, Phalak, Thayanithy (bib0065) 2010; 90 Voelter-Mahlknecht, Letzel, Mahlknecht (bib0090) 2006; 28 Shi, Li, Qian (bib0110) 2017; 8 Tang, Shi, Xie (bib0280) 2017; 8 Wei, Qiao, Li (bib0115) 2016; 35 Kiran, Anwar, Kiran (bib0070) 2015; 27 Kasinski, Slack (bib0050) 2011; 11 Li, Gong, Chen (bib0190) 2015; 460 Fernandez, Risolino, Mandia (bib0200) 2015; 34 Bartel (bib0030) 2004; 116 Wu, Wu, Wang (bib0180) 2011; 117 Li, Bhatia (bib0245) 2013; 23 Yin, Zhou, Xue (bib0230) 2016; 36 Kim, Noh, Jung (bib0285) 2013; 57 Paredes, Villanova, Chua (bib0235) 2014; 20 Aljada, Saleh, Alkathiri (bib0095) 2015; 9 Agarwal, Bell, Nam (bib0145) 2015; 4 Takeyama, Yamamoto, Yamashita (bib0205) 2014; 13 Huang, Tang, He (bib0215) 2016; 35 Zhan, Lei, Li (bib0320) 2017; 94 Heishima, Mori, Ichikawa (bib0160) 2015; 16 Yu, Zhang, Lu (bib0220) 2016; 577 Blank, Grummt (bib0075) 2017; 8 Esquela-Kerscher, Slack (bib0060) 2006; 6 Rottiers, Naar (bib0045) 2012; 13 Li, Li (bib0300) 2017; 16 Chen, Kuang, Zhao (bib0170) 2016; 7 Betel, Wilson, Gabow (bib0150) 2008; 36 Tang, Lu, Zhang (bib0255) 2017; 7 Wang, Lin, Nie (bib0315) 2017; 16 Albores-Saavedra, Schwartz, Henson (bib0005) 2011; 15 Cioffi, Vallespinos-Serrano, Trabulo (bib0305) 2015; 12 Zhang (bib0040) 2008; 33 Winter, Jung, Keller (bib0035) 2009; 11 Hou, Yu, Xie (bib0185) 2016; 7 Barber, Michishita-Kioi, Xi (bib0240) 2012; 487 Grob, Roussel, Wright (bib0080) 2009; 122 Martinez-Redondo, Santos-Barriopedro, Vaquero (bib0250) 2012; 21 Zhou, Wei, Wang (bib0225) 2013; 437 Malik, Villanova, Tanaka (bib0270) 2015; 5 Yamashita, Kondo, Ohue (bib0195) 2015; 75 Wang, Xiang, Chen (bib0140) 2018; 146 Italiano, Thomas, Breen (bib0155) 2012; 51 Zhang, Chen, Huang (bib0265) 2015; 5 Agulnik, Yarber, Okuno (bib0015) 2013; 24 Yin (10.1016/j.biopha.2018.04.148_bib0230) 2016; 36 Ford (10.1016/j.biopha.2018.04.148_bib0085) 2006; 20 Kiran (10.1016/j.biopha.2018.04.148_bib0070) 2015; 27 Italiano (10.1016/j.biopha.2018.04.148_bib0155) 2012; 51 Han (10.1016/j.biopha.2018.04.148_bib0290) 2013; 587 Nakashima (10.1016/j.biopha.2018.04.148_bib0175) 2017; 27 Wang (10.1016/j.biopha.2018.04.148_bib0315) 2017; 16 Huang (10.1016/j.biopha.2018.04.148_bib0125) 2018; 37 Winter (10.1016/j.biopha.2018.04.148_bib0035) 2009; 11 Bartel (10.1016/j.biopha.2018.04.148_bib0030) 2004; 116 Huang (10.1016/j.biopha.2018.04.148_bib0120) 2015; 6 Wang (10.1016/j.biopha.2018.04.148_bib0140) 2018; 146 Betel (10.1016/j.biopha.2018.04.148_bib0150) 2008; 36 Lahat (10.1016/j.biopha.2018.04.148_bib0010) 2010; 251 Heishima (10.1016/j.biopha.2018.04.148_bib0160) 2015; 16 Voelter-Mahlknecht (10.1016/j.biopha.2018.04.148_bib0090) 2006; 28 Wei (10.1016/j.biopha.2018.04.148_bib0115) 2016; 35 Sarver (10.1016/j.biopha.2018.04.148_bib0065) 2010; 90 Garzon (10.1016/j.biopha.2018.04.148_bib0055) 2009; 60 Agulnik (10.1016/j.biopha.2018.04.148_bib0015) 2013; 24 Kiran (10.1016/j.biopha.2018.04.148_bib0260) 2015; 331 Hou (10.1016/j.biopha.2018.04.148_bib0185) 2016; 7 Agarwal (10.1016/j.biopha.2018.04.148_bib0145) 2015; 4 Kasinski (10.1016/j.biopha.2018.04.148_bib0050) 2011; 11 Li (10.1016/j.biopha.2018.04.148_bib0245) 2013; 23 Wu (10.1016/j.biopha.2018.04.148_bib0180) 2011; 117 Yu (10.1016/j.biopha.2018.04.148_bib0220) 2016; 577 Li (10.1016/j.biopha.2018.04.148_bib0190) 2015; 460 Yu (10.1016/j.biopha.2018.04.148_bib0275) 2017; 18 Zhang (10.1016/j.biopha.2018.04.148_bib0265) 2015; 5 He (10.1016/j.biopha.2018.04.148_bib0020) 2004; 5 Zhao (10.1016/j.biopha.2018.04.148_bib0135) 2018 Xie (10.1016/j.biopha.2018.04.148_bib0130) 2018; 50 Fernandez (10.1016/j.biopha.2018.04.148_bib0200) 2015; 34 Wei (10.1016/j.biopha.2018.04.148_bib0105) 2017; 7 Paredes (10.1016/j.biopha.2018.04.148_bib0235) 2014; 20 Blank (10.1016/j.biopha.2018.04.148_bib0075) 2017; 8 Martinez-Redondo (10.1016/j.biopha.2018.04.148_bib0250) 2012; 21 Aljada (10.1016/j.biopha.2018.04.148_bib0095) 2015; 9 Zhou (10.1016/j.biopha.2018.04.148_bib0225) 2013; 437 Tang (10.1016/j.biopha.2018.04.148_bib0280) 2017; 8 Zhan (10.1016/j.biopha.2018.04.148_bib0320) 2017; 94 Li (10.1016/j.biopha.2018.04.148_bib0210) 2016; 38 Shi (10.1016/j.biopha.2018.04.148_bib0295) 2016; 36 Li (10.1016/j.biopha.2018.04.148_bib0300) 2017; 16 Heishima (10.1016/j.biopha.2018.04.148_bib0165) 2015; 10 Takeyama (10.1016/j.biopha.2018.04.148_bib0205) 2014; 13 Hutvagner (10.1016/j.biopha.2018.04.148_bib0025) 2002; 297 Shi (10.1016/j.biopha.2018.04.148_bib0110) 2017; 8 Huang (10.1016/j.biopha.2018.04.148_bib0215) 2016; 35 Albores-Saavedra (10.1016/j.biopha.2018.04.148_bib0005) 2011; 15 Rottiers (10.1016/j.biopha.2018.04.148_bib0045) 2012; 13 Barber (10.1016/j.biopha.2018.04.148_bib0240) 2012; 487 Gu (10.1016/j.biopha.2018.04.148_bib0310) 2016; 590 Yu (10.1016/j.biopha.2018.04.148_bib0100) 2014; 20 Tang (10.1016/j.biopha.2018.04.148_bib0255) 2017; 7 Grob (10.1016/j.biopha.2018.04.148_bib0080) 2009; 122 Esquela-Kerscher (10.1016/j.biopha.2018.04.148_bib0060) 2006; 6 Cioffi (10.1016/j.biopha.2018.04.148_bib0305) 2015; 12 Malik (10.1016/j.biopha.2018.04.148_bib0270) 2015; 5 Chen (10.1016/j.biopha.2018.04.148_bib0170) 2016; 7 Zhang (10.1016/j.biopha.2018.04.148_bib0040) 2008; 33 Kim (10.1016/j.biopha.2018.04.148_bib0285) 2013; 57 Yamashita (10.1016/j.biopha.2018.04.148_bib0195) 2015; 75 |
| References_xml | – volume: 487 start-page: 114 year: 2012 end-page: 118 ident: bib0240 article-title: SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation publication-title: Nature – volume: 23 start-page: 10 year: 2013 end-page: 12 ident: bib0245 article-title: The controversial role of Sirtuins in tumorigenesis - SIRT7 joins the debate publication-title: Cell Res. – volume: 37 start-page: 1159 year: 2018 end-page: 1174 ident: bib0125 article-title: SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis publication-title: Oncogene – volume: 50 start-page: 291 year: 2018 end-page: 296 ident: bib0130 article-title: Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene publication-title: Dig. Liver Dis. – volume: 10 start-page: e0137361 year: 2015 ident: bib0165 article-title: MicroRNA-214 promotes apoptosis in canine hemangiosarcoma by targeting the COP1-p53 axis publication-title: PLoS One – volume: 7 start-page: 26016 year: 2016 end-page: 26026 ident: bib0185 article-title: miR-340 and ZEB1 negative feedback loop regulates TGF-beta- mediated breast cancer progression publication-title: Oncotarget – volume: 7 start-page: 1788 year: 2017 end-page: 1803 ident: bib0105 article-title: Sirtuin 7 plays an oncogenic role in human osteosarcoma via downregulating CDC4 expression publication-title: Am. J. Cancer Res. – volume: 18 start-page: 1229 year: 2017 end-page: 1240 ident: bib0275 article-title: Regulation of serine-threonine kinase Akt activation by NAD+-dependent deacetylase SIRT7 publication-title: Cell Rep. – volume: 5 start-page: 522 year: 2004 end-page: 531 ident: bib0020 article-title: MicroRNAs: small RNAs with a big role in gene regulation publication-title: Nat. Rev. Genet. – volume: 5 start-page: 9787 year: 2015 ident: bib0265 article-title: Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a publication-title: Sci. Rep. – volume: 51 start-page: 569 year: 2012 end-page: 578 ident: bib0155 article-title: The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification publication-title: Genes Chromosom. Cancer – volume: 94 start-page: 394 year: 2017 end-page: 401 ident: bib0320 article-title: Suppression of microRNA-142-5p attenuates hypoxia-induced apoptosis through targeting SIRT7 publication-title: Biomed. Pharmacother. – volume: 146 start-page: 56 year: 2018 end-page: 67 ident: bib0140 article-title: Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma publication-title: Biochimie – volume: 20 start-page: 1741 year: 2014 end-page: 1746 ident: bib0235 article-title: Molecular pathways: emerging roles of mammalian Sirtuin SIRT7 in cancer publication-title: Clin. Cancer Res. – volume: 5 start-page: 9841 year: 2015 ident: bib0270 article-title: SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors publication-title: Sci. Rep. – volume: 35 start-page: 887 year: 2016 end-page: 895 ident: bib0215 article-title: MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway publication-title: Oncol. Rep. – volume: 34 start-page: 3240 year: 2015 end-page: 3250 ident: bib0200 article-title: miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer publication-title: Oncogene – volume: 16 start-page: 25377 year: 2015 end-page: 25391 ident: bib0160 article-title: MicroRNA-214 and microRNA-126 are potential biomarkers for malignant endothelial proliferative diseases publication-title: Int. J. Mol. Sci. – volume: 15 start-page: 93 year: 2011 end-page: 97 ident: bib0005 article-title: Cutaneous angiosarcoma. Analysis of 434 cases from the surveillance, epidemiology, and End results program, 1973-2007 publication-title: Ann. Diagn. Pathol. – volume: 13 start-page: 239 year: 2012 end-page: 250 ident: bib0045 article-title: MicroRNAs in metabolism and metabolic disorders publication-title: Nat. Rev. Mol. Cell Biol. – volume: 122 start-page: 489 year: 2009 end-page: 498 ident: bib0080 article-title: Involvement of SIRT7 in resumption of rDNA transcription at the exit from mitosis publication-title: J. Cell Sci. – volume: 7 start-page: 1346 year: 2017 end-page: 1359 ident: bib0255 article-title: Downregulation of SIRT7 by 5-fluorouracil induces radiosensitivity in human colorectal cancer publication-title: Theranostics – volume: 24 start-page: 257 year: 2013 end-page: 263 ident: bib0015 article-title: An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas publication-title: Ann. Oncol. – volume: 331 start-page: 123 year: 2015 end-page: 141 ident: bib0260 article-title: Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response publication-title: Exp. Cell Res. – volume: 8 start-page: 67 year: 2017 end-page: 74 ident: bib0075 article-title: The seven faces of SIRT7 publication-title: Transcription – volume: 437 start-page: 653 year: 2013 end-page: 658 ident: bib0225 article-title: MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1 publication-title: Biochem. Biophys. Res. Commun. – volume: 460 start-page: 670 year: 2015 end-page: 677 ident: bib0190 article-title: miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2 publication-title: Biochem. Biophys. Res. Commun. – volume: 36 start-page: 1111 year: 2016 end-page: 1118 ident: bib0230 article-title: MicroRNA-340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2 publication-title: Oncol. Rep. – volume: 7 start-page: 58148 year: 2016 end-page: 58161 ident: bib0170 article-title: miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma publication-title: Oncotarget – volume: 6 start-page: 9257 year: 2015 end-page: 9270 ident: bib0120 article-title: miR-340 suppresses glioblastoma multiforme publication-title: Oncotarget – volume: 4 start-page: 1 year: 2015 end-page: 38 ident: bib0145 article-title: Predicting effective microRNA target sites in mammalian mRNAs publication-title: Elife – volume: 28 start-page: 899 year: 2006 end-page: 908 ident: bib0090 article-title: Fluorescence in situ hybridization and chromosomal organization of the human Sirtuin 7 gene publication-title: Int. J. Oncol. – volume: 33 start-page: 139 year: 2008 end-page: 147 ident: bib0040 article-title: MicroRNomics: a newly emerging approach for disease biology publication-title: Physiol. Genomics – volume: 57 start-page: 1055 year: 2013 end-page: 1067 ident: bib0285 article-title: Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b publication-title: Hepatology – volume: 38 start-page: 1915 year: 2016 end-page: 1927 ident: bib0210 article-title: MicroRNA-340 induces apoptosis and inhibits metastasis of ovarian cancer cells by inactivation of NF-κB publication-title: Cell. Physiol. Biochem. – volume: 297 start-page: 2056 year: 2002 end-page: 2060 ident: bib0025 article-title: A microRNA in a multiple-turnover RNAi enzyme complex publication-title: Science – volume: 6 start-page: 259 year: 2006 end-page: 269 ident: bib0060 article-title: Oncomirs - microRNAs with a role in cancer publication-title: Nat. Rev. Cancer – volume: 20 start-page: 1075 year: 2006 end-page: 1080 ident: bib0085 article-title: Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription publication-title: Genes Dev. – volume: 75 start-page: 1123 year: 2015 end-page: 1133 ident: bib0195 article-title: miR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator publication-title: Cancer Res. – volume: 12 start-page: 1594 year: 2015 end-page: 1605 ident: bib0305 article-title: MiR-93 controls adiposity via inhibition of Sirt7 and Tbx3 publication-title: Cell Rep. – volume: 116 start-page: 281 year: 2004 end-page: 297 ident: bib0030 article-title: MicroRNAs: genomics, biogenesis, mechanism, and function publication-title: Cell – volume: 21 start-page: 719 year: 2012 end-page: 721 ident: bib0250 article-title: A big step for SIRT7, one giant leap for Sirtuins in cancer publication-title: Cancer Cell – volume: 587 start-page: 3875 year: 2013 end-page: 3882 ident: bib0290 article-title: Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1 publication-title: FEBS Lett. – volume: 16 start-page: 8493 year: 2017 end-page: 8500 ident: bib0300 article-title: MicroRNA3666 inhibits breast cancer cell proliferation by targeting sirtuin 7 publication-title: Mol. Med. Rep. – volume: 590 start-page: 1123 year: 2016 end-page: 1131 ident: bib0310 article-title: miR-152 induces human dental pulp stem cell senescence by inhibiting SIRT7 expression publication-title: FEBS Lett. – volume: 27 start-page: 464 year: 2017 end-page: 471 ident: bib0175 article-title: The role of miR-210, E2F3 and ephrin A3 in angiosarcoma cell proliferation publication-title: Eur. J. Dermatol. – volume: 16 start-page: 5667 year: 2017 end-page: 5674 ident: bib0315 article-title: microRNA-20b contributes to high glucose-induced podocyte apoptosis by targeting SIRT7 publication-title: Mol. Med. Rep. – volume: 20 start-page: 3434 year: 2014 end-page: 3445 ident: bib0100 article-title: Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer publication-title: Clin. Cancer Res. – volume: 35 start-page: 33 year: 2016 end-page: 43 ident: bib0115 article-title: microRNA-340 suppresses tumorigenic potential of prostate cancer cells by targeting high-mobility group nucleosome-binding domain 5 publication-title: DNA Cell Biol. – volume: 11 start-page: 849 year: 2011 end-page: 864 ident: bib0050 article-title: Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy publication-title: Nat. Rev. Cancer – volume: 36 start-page: D149 year: 2008 end-page: 153 ident: bib0150 article-title: The microRNA.org resource: targets and expression publication-title: Nucleic Acids Res. – volume: 251 start-page: 1098 year: 2010 end-page: 1106 ident: bib0010 article-title: Angiosarcoma: clinical and molecular insights publication-title: Ann. Surg. – year: 2018 ident: bib0135 article-title: Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4 publication-title: J. Endocrinol. Invest. – volume: 8 start-page: 3037 year: 2017 end-page: 3048 ident: bib0110 article-title: MiR-340 inhibits triple-negative breast cancer progression by reversing EZH2 mediated miRNAs dysregulated expressions publication-title: J. Cancer – volume: 90 start-page: 753 year: 2010 end-page: 761 ident: bib0065 article-title: S-MED: sarcoma microRNA expression database publication-title: Lab. Invest. – volume: 9 start-page: 3 year: 2015 end-page: 8 ident: bib0095 article-title: Altered sirtuin 7 expression is associated with early stage breast cancer publication-title: Breast Cancer (Auckl.) – volume: 577 start-page: 193 year: 2016 end-page: 201 ident: bib0220 article-title: MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2 publication-title: Gene – volume: 36 start-page: 3051 year: 2016 end-page: 3057 ident: bib0295 article-title: MicroRNA-3666-induced suppression of SIRT7 inhibits the growth of non-small cell lung cancer cells publication-title: Oncol. Rep. – volume: 60 start-page: 167 year: 2009 end-page: 179 ident: bib0055 article-title: MicroRNAs in cancer publication-title: Annu. Rev. Med. – volume: 27 start-page: 673 year: 2015 end-page: 682 ident: bib0070 article-title: Sirtuin 7 in cell proliferation, stress and disease: rise of the seventh sirtuin! publication-title: Cell Signal. – volume: 117 start-page: 2842 year: 2011 end-page: 2852 ident: bib0180 article-title: miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met publication-title: Cancer – volume: 13 start-page: 976 year: 2014 end-page: 985 ident: bib0205 article-title: Decreased miR-340 expression in bone marrow is associated with liver metastasis of colorectal cancer publication-title: Mol. Cancer Ther. – volume: 11 start-page: 228 year: 2009 end-page: 234 ident: bib0035 article-title: Many roads to maturity: microRNA biogenesis pathways and their regulation publication-title: Nat. Cell Biol. – volume: 8 start-page: 318 year: 2017 ident: bib0280 article-title: SIRT7 antagonizes TGF-beta signaling and inhibits breast cancer metastasis publication-title: Nat. Commun. – volume: 24 start-page: 257 year: 2013 ident: 10.1016/j.biopha.2018.04.148_bib0015 article-title: An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas publication-title: Ann. Oncol. doi: 10.1093/annonc/mds237 – volume: 116 start-page: 281 year: 2004 ident: 10.1016/j.biopha.2018.04.148_bib0030 article-title: MicroRNAs: genomics, biogenesis, mechanism, and function publication-title: Cell doi: 10.1016/S0092-8674(04)00045-5 – volume: 6 start-page: 9257 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0120 article-title: miR-340 suppresses glioblastoma multiforme publication-title: Oncotarget doi: 10.18632/oncotarget.3288 – volume: 16 start-page: 25377 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0160 article-title: MicroRNA-214 and microRNA-126 are potential biomarkers for malignant endothelial proliferative diseases publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms161025377 – volume: 6 start-page: 259 year: 2006 ident: 10.1016/j.biopha.2018.04.148_bib0060 article-title: Oncomirs - microRNAs with a role in cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1840 – volume: 4 start-page: 1 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0145 article-title: Predicting effective microRNA target sites in mammalian mRNAs publication-title: Elife doi: 10.7554/eLife.05005 – volume: 8 start-page: 3037 year: 2017 ident: 10.1016/j.biopha.2018.04.148_bib0110 article-title: MiR-340 inhibits triple-negative breast cancer progression by reversing EZH2 mediated miRNAs dysregulated expressions publication-title: J. Cancer doi: 10.7150/jca.19315 – volume: 7 start-page: 26016 year: 2016 ident: 10.1016/j.biopha.2018.04.148_bib0185 article-title: miR-340 and ZEB1 negative feedback loop regulates TGF-beta- mediated breast cancer progression publication-title: Oncotarget doi: 10.18632/oncotarget.8421 – volume: 460 start-page: 670 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0190 article-title: miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2015.03.088 – volume: 11 start-page: 849 year: 2011 ident: 10.1016/j.biopha.2018.04.148_bib0050 article-title: Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3166 – volume: 57 start-page: 1055 year: 2013 ident: 10.1016/j.biopha.2018.04.148_bib0285 article-title: Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b publication-title: Hepatology doi: 10.1002/hep.26101 – volume: 251 start-page: 1098 year: 2010 ident: 10.1016/j.biopha.2018.04.148_bib0010 article-title: Angiosarcoma: clinical and molecular insights publication-title: Ann. Surg. doi: 10.1097/SLA.0b013e3181dbb75a – volume: 21 start-page: 719 year: 2012 ident: 10.1016/j.biopha.2018.04.148_bib0250 article-title: A big step for SIRT7, one giant leap for Sirtuins in cancer publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.05.028 – volume: 8 start-page: 67 year: 2017 ident: 10.1016/j.biopha.2018.04.148_bib0075 article-title: The seven faces of SIRT7 publication-title: Transcription doi: 10.1080/21541264.2016.1276658 – volume: 10 start-page: e0137361 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0165 article-title: MicroRNA-214 promotes apoptosis in canine hemangiosarcoma by targeting the COP1-p53 axis publication-title: PLoS One doi: 10.1371/journal.pone.0137361 – volume: 60 start-page: 167 year: 2009 ident: 10.1016/j.biopha.2018.04.148_bib0055 article-title: MicroRNAs in cancer publication-title: Annu. Rev. Med. doi: 10.1146/annurev.med.59.053006.104707 – volume: 7 start-page: 1346 year: 2017 ident: 10.1016/j.biopha.2018.04.148_bib0255 article-title: Downregulation of SIRT7 by 5-fluorouracil induces radiosensitivity in human colorectal cancer publication-title: Theranostics doi: 10.7150/thno.18804 – volume: 117 start-page: 2842 year: 2011 ident: 10.1016/j.biopha.2018.04.148_bib0180 article-title: miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met publication-title: Cancer doi: 10.1002/cncr.25860 – volume: 7 start-page: 1788 year: 2017 ident: 10.1016/j.biopha.2018.04.148_bib0105 article-title: Sirtuin 7 plays an oncogenic role in human osteosarcoma via downregulating CDC4 expression publication-title: Am. J. Cancer Res. – volume: 331 start-page: 123 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0260 article-title: Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2014.11.001 – volume: 27 start-page: 673 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0070 article-title: Sirtuin 7 in cell proliferation, stress and disease: rise of the seventh sirtuin! publication-title: Cell Signal. doi: 10.1016/j.cellsig.2014.11.026 – volume: 20 start-page: 1741 year: 2014 ident: 10.1016/j.biopha.2018.04.148_bib0235 article-title: Molecular pathways: emerging roles of mammalian Sirtuin SIRT7 in cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-13-1547 – volume: 13 start-page: 976 year: 2014 ident: 10.1016/j.biopha.2018.04.148_bib0205 article-title: Decreased miR-340 expression in bone marrow is associated with liver metastasis of colorectal cancer publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-13-0571 – volume: 18 start-page: 1229 year: 2017 ident: 10.1016/j.biopha.2018.04.148_bib0275 article-title: Regulation of serine-threonine kinase Akt activation by NAD+-dependent deacetylase SIRT7 publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.01.009 – volume: 75 start-page: 1123 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0195 article-title: miR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-14-0938 – volume: 587 start-page: 3875 year: 2013 ident: 10.1016/j.biopha.2018.04.148_bib0290 article-title: Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1 publication-title: FEBS Lett. doi: 10.1016/j.febslet.2013.10.023 – volume: 35 start-page: 887 year: 2016 ident: 10.1016/j.biopha.2018.04.148_bib0215 article-title: MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway publication-title: Oncol. Rep. doi: 10.3892/or.2015.4458 – volume: 28 start-page: 899 year: 2006 ident: 10.1016/j.biopha.2018.04.148_bib0090 article-title: Fluorescence in situ hybridization and chromosomal organization of the human Sirtuin 7 gene publication-title: Int. J. Oncol. – volume: 51 start-page: 569 year: 2012 ident: 10.1016/j.biopha.2018.04.148_bib0155 article-title: The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification publication-title: Genes Chromosom. Cancer doi: 10.1002/gcc.21943 – volume: 12 start-page: 1594 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0305 article-title: MiR-93 controls adiposity via inhibition of Sirt7 and Tbx3 publication-title: Cell Rep. doi: 10.1016/j.celrep.2015.08.006 – volume: 437 start-page: 653 year: 2013 ident: 10.1016/j.biopha.2018.04.148_bib0225 article-title: MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2013.07.033 – volume: 23 start-page: 10 year: 2013 ident: 10.1016/j.biopha.2018.04.148_bib0245 article-title: The controversial role of Sirtuins in tumorigenesis - SIRT7 joins the debate publication-title: Cell Res. doi: 10.1038/cr.2012.112 – volume: 20 start-page: 1075 year: 2006 ident: 10.1016/j.biopha.2018.04.148_bib0085 article-title: Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription publication-title: Genes Dev. doi: 10.1101/gad.1399706 – volume: 577 start-page: 193 year: 2016 ident: 10.1016/j.biopha.2018.04.148_bib0220 article-title: MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2 publication-title: Gene doi: 10.1016/j.gene.2015.11.045 – volume: 16 start-page: 5667 year: 2017 ident: 10.1016/j.biopha.2018.04.148_bib0315 article-title: microRNA-20b contributes to high glucose-induced podocyte apoptosis by targeting SIRT7 publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2017.7224 – volume: 11 start-page: 228 year: 2009 ident: 10.1016/j.biopha.2018.04.148_bib0035 article-title: Many roads to maturity: microRNA biogenesis pathways and their regulation publication-title: Nat. Cell Biol. doi: 10.1038/ncb0309-228 – volume: 8 start-page: 318 year: 2017 ident: 10.1016/j.biopha.2018.04.148_bib0280 article-title: SIRT7 antagonizes TGF-beta signaling and inhibits breast cancer metastasis publication-title: Nat. Commun. doi: 10.1038/s41467-017-00396-9 – volume: 5 start-page: 522 year: 2004 ident: 10.1016/j.biopha.2018.04.148_bib0020 article-title: MicroRNAs: small RNAs with a big role in gene regulation publication-title: Nat. Rev. Genet. doi: 10.1038/nrg1379 – year: 2018 ident: 10.1016/j.biopha.2018.04.148_bib0135 article-title: Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4 publication-title: J. Endocrinol. Invest. doi: 10.1007/s40618-018-0848-6 – volume: 13 start-page: 239 year: 2012 ident: 10.1016/j.biopha.2018.04.148_bib0045 article-title: MicroRNAs in metabolism and metabolic disorders publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm3313 – volume: 94 start-page: 394 year: 2017 ident: 10.1016/j.biopha.2018.04.148_bib0320 article-title: Suppression of microRNA-142-5p attenuates hypoxia-induced apoptosis through targeting SIRT7 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2017.07.083 – volume: 90 start-page: 753 year: 2010 ident: 10.1016/j.biopha.2018.04.148_bib0065 article-title: S-MED: sarcoma microRNA expression database publication-title: Lab. Invest. doi: 10.1038/labinvest.2010.53 – volume: 33 start-page: 139 year: 2008 ident: 10.1016/j.biopha.2018.04.148_bib0040 article-title: MicroRNomics: a newly emerging approach for disease biology publication-title: Physiol. Genomics doi: 10.1152/physiolgenomics.00034.2008 – volume: 297 start-page: 2056 year: 2002 ident: 10.1016/j.biopha.2018.04.148_bib0025 article-title: A microRNA in a multiple-turnover RNAi enzyme complex publication-title: Science doi: 10.1126/science.1073827 – volume: 590 start-page: 1123 year: 2016 ident: 10.1016/j.biopha.2018.04.148_bib0310 article-title: miR-152 induces human dental pulp stem cell senescence by inhibiting SIRT7 expression publication-title: FEBS Lett. doi: 10.1002/1873-3468.12138 – volume: 27 start-page: 464 year: 2017 ident: 10.1016/j.biopha.2018.04.148_bib0175 article-title: The role of miR-210, E2F3 and ephrin A3 in angiosarcoma cell proliferation publication-title: Eur. J. Dermatol. doi: 10.1684/ejd.2017.3084 – volume: 7 start-page: 58148 year: 2016 ident: 10.1016/j.biopha.2018.04.148_bib0170 article-title: miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma publication-title: Oncotarget doi: 10.18632/oncotarget.11252 – volume: 38 start-page: 1915 year: 2016 ident: 10.1016/j.biopha.2018.04.148_bib0210 article-title: MicroRNA-340 induces apoptosis and inhibits metastasis of ovarian cancer cells by inactivation of NF-κB publication-title: Cell. Physiol. Biochem. doi: 10.1159/000445553 – volume: 15 start-page: 93 year: 2011 ident: 10.1016/j.biopha.2018.04.148_bib0005 article-title: Cutaneous angiosarcoma. Analysis of 434 cases from the surveillance, epidemiology, and End results program, 1973-2007 publication-title: Ann. Diagn. Pathol. doi: 10.1016/j.anndiagpath.2010.07.012 – volume: 9 start-page: 3 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0095 article-title: Altered sirtuin 7 expression is associated with early stage breast cancer publication-title: Breast Cancer (Auckl.) – volume: 5 start-page: 9841 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0270 article-title: SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors publication-title: Sci. Rep. doi: 10.1038/srep09841 – volume: 36 start-page: D149 year: 2008 ident: 10.1016/j.biopha.2018.04.148_bib0150 article-title: The microRNA.org resource: targets and expression publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkm995 – volume: 36 start-page: 3051 year: 2016 ident: 10.1016/j.biopha.2018.04.148_bib0295 article-title: MicroRNA-3666-induced suppression of SIRT7 inhibits the growth of non-small cell lung cancer cells publication-title: Oncol. Rep. doi: 10.3892/or.2016.5063 – volume: 16 start-page: 8493 year: 2017 ident: 10.1016/j.biopha.2018.04.148_bib0300 article-title: MicroRNA3666 inhibits breast cancer cell proliferation by targeting sirtuin 7 publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2017.7603 – volume: 146 start-page: 56 year: 2018 ident: 10.1016/j.biopha.2018.04.148_bib0140 article-title: Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma publication-title: Biochimie doi: 10.1016/j.biochi.2017.10.027 – volume: 36 start-page: 1111 year: 2016 ident: 10.1016/j.biopha.2018.04.148_bib0230 article-title: MicroRNA-340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2 publication-title: Oncol. Rep. doi: 10.3892/or.2016.4876 – volume: 487 start-page: 114 year: 2012 ident: 10.1016/j.biopha.2018.04.148_bib0240 article-title: SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation publication-title: Nature doi: 10.1038/nature11043 – volume: 34 start-page: 3240 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0200 article-title: miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer publication-title: Oncogene doi: 10.1038/onc.2014.267 – volume: 5 start-page: 9787 year: 2015 ident: 10.1016/j.biopha.2018.04.148_bib0265 article-title: Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a publication-title: Sci. Rep. doi: 10.1038/srep09787 – volume: 20 start-page: 3434 year: 2014 ident: 10.1016/j.biopha.2018.04.148_bib0100 article-title: Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-13-2952 – volume: 37 start-page: 1159 year: 2018 ident: 10.1016/j.biopha.2018.04.148_bib0125 article-title: SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis publication-title: Oncogene doi: 10.1038/s41388-017-0029-7 – volume: 122 start-page: 489 year: 2009 ident: 10.1016/j.biopha.2018.04.148_bib0080 article-title: Involvement of SIRT7 in resumption of rDNA transcription at the exit from mitosis publication-title: J. Cell Sci. doi: 10.1242/jcs.042382 – volume: 50 start-page: 291 year: 2018 ident: 10.1016/j.biopha.2018.04.148_bib0130 article-title: Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene publication-title: Dig. Liver Dis. doi: 10.1016/j.dld.2017.10.024 – volume: 35 start-page: 33 year: 2016 ident: 10.1016/j.biopha.2018.04.148_bib0115 article-title: microRNA-340 suppresses tumorigenic potential of prostate cancer cells by targeting high-mobility group nucleosome-binding domain 5 publication-title: DNA Cell Biol. doi: 10.1089/dna.2015.3021 |
| SSID | ssj0005638 |
| Score | 2.3121123 |
| Snippet | MicroRNAs (miRNAs) are emerging as critical regulators for the development and progression of various cancers, including angiosarcoma. Accumulating evidence... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1061 |
| SubjectTerms | Angiosarcoma miR-340 miRNA SIRT7 |
| Title | MicroRNA-340 inhibits the growth and invasion of angiosarcoma cells by targeting SIRT7 |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0753332218305183 https://dx.doi.org/10.1016/j.biopha.2018.04.148 https://www.ncbi.nlm.nih.gov/pubmed/29710664 https://www.proquest.com/docview/2033376998 |
| Volume | 103 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hKlVcqpaWdvtArlRxwmw2dhzvcYWKlqJdIVgqbpHj2BDUJqgJlfbS396ZPBaQiqg42rKVxJ6Zb-x8MwPwRSDqKd8wagLNpTGK61RarkJvQ4SLTDYkmtlcTc_kt_PofA32-1gYolV2tr-16Y217nqG3WoOr_N8eIpgJwTKIwolSpamjJ9SxiTle3_u0DxUU82aBnMa3YfPNRyvNC8pKROCoKaEpyOqAvRveHrI_Wxg6OAlvOj8RzZpX_EVrLliE57Puj_km7Bz3OaiXu6yxW1oVbXLdtjxbZbq5Wv4PiMq3sl8woUMWF5c5mleVwz9QXaBR_P6kpkiw_7fhu7TWOmxfZGXFSpG-dMwuvCvWLpkLZUcAZCdHp4s4jdwdvB1sT_lXZEFbqUe1VxL71TqlNShFVFgI6-MNiIwSrsolajwAvuwf2zRuDlKgh4LGwZ-7JyNwkxswXpRFu4dMBGN0piCgeNMS62szqTxfmwD5TMRmWwAol_bxHYZyKkQxo-kp5pdJe2OJLQjSSDxYKIHwFezrtsMHI-Mj_ptS_roUrSHCULEI_Pi1bx7EvgfMz_30pGgctIGmMKVNxUOQgmNFR5pB_C2FZvVN4RjdO6Uku-f_NwPsEGtljz8EdbrXzfuE7pIdbrd6MA2PJscHk3nfwEa9A5l |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-6FLa9jK37yj41GH2qiGN9WHkMZSVZm1DadPRNyLLUemx2md1B_vud_JEw2OjYo886bOtOdyf5d3cAHxl6PekbRE2kKDdGUpVyS2XsbYzuIuMNiGaxlLML_vlSXO7AYZ8LE2CVne1vbXpjrTvKqJvN0U2ej87R2TGG-ohKiZql2D3YDdWpxAB2p_Pj2XKL9JBNQ-swngaGPoOugXmleRnqMqEfVKHm6Tg0Avqzh_pbBNp4oqPH8KgLIcm0fcsnsOOKPbi_6H6S78H-aVuOen1AVtvsquqA7JPTbaHq9VP4sghovLPllDIekby4ztO8rgiGhOQKd-f1NTFFhvSfJhypkdLj9VVeVrg2yu-GhDP_iqRr0qLJ0QeS8_nZKnkGF0efVocz2vVZoJarcU0V906mTnIVWyYiK7w0yrDISOVEynHNM6QhfWLRvrlQBz1hNo78xDkr4ow9h0FRFu4lECbGaRLygZNMcSWtyrjxfmIj6TMmTDYE1s-ttl0R8tAL45vu0WZfdSsRHSSiI457EzUEuuG6aYtw3DFe9GLTfYIpmkSNXuIOvmTD95sS_gPnh147NK7PIABTuPK2wkGopInEXe0QXrRqs_mGeILxnZT81X8_9z08mK0WJ_pkvjx-DQ_DnRZL_AYG9Y9b9xYjpjp9162IX1UwERY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA-340+inhibits+the+growth+and+invasion+of+angiosarcoma+cells+by+targeting+SIRT7&rft.jtitle=Biomedicine+%26+pharmacotherapy&rft.au=Wang%2C+Xiaoxin&rft.au=Song%2C+Ying&rft.date=2018-07-01&rft.issn=1950-6007&rft.eissn=1950-6007&rft.volume=103&rft.spage=1061&rft_id=info:doi/10.1016%2Fj.biopha.2018.04.148&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0753-3322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0753-3322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0753-3322&client=summon |